Akebia Therapeutics (AX9.STU) Q2 2026 Earnings

7MayConfirmed
Q1 2026
Q2 2026
-0.04
-0.04
-0.03
-0.02

Details

Expected EPS
-0.023874760000000002
Actual EPS
-0.0255801
Surprise EPS
-0
Surprise Percent
+7.14%

Description

Akebia Therapeutics (AX9.STU) has reported earnings of -0.0255801 per share for Q2 2026.

0 Comments

Share your thoughts